Data as of Dec 10
| -0.16 / -4.52%|
The 1 analysts offering 12-month price forecasts for Aastrom Biosciences Inc have a median target of 4.50, with a high estimate of 4.50 and a low estimate of 4.50. The median estimate represents a +33.14% increase from the last price of 3.38.
The current consensus among 3 polled investment analysts is to Hold stock in Aastrom Biosciences Inc. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.